Cargando…

Utilisation des bactéries lactiques comme vecteurs vaccinaux

Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermúdez-Humarán, Luis G., Langella, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270964/
https://www.ncbi.nlm.nih.gov/pubmed/32518601
http://dx.doi.org/10.1016/S1773-035X(09)70312-0
_version_ 1783541997386072064
author Bermúdez-Humarán, Luis G.
Langella, Philippe
author_facet Bermúdez-Humarán, Luis G.
Langella, Philippe
author_sort Bermúdez-Humarán, Luis G.
collection PubMed
description Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to produce fermented foods. They are thus good candidates to develop novel oral vectors and constitute attractive alternatives to vaccinal strategies based on attenuated pathogens which could induce healthy risks. Here, we summarized the most recent researches performed on the use of LAB as live vaccine delivery vectors.
format Online
Article
Text
id pubmed-7270964
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-72709642020-06-05 Utilisation des bactéries lactiques comme vecteurs vaccinaux Bermúdez-Humarán, Luis G. Langella, Philippe Rev Francoph Lab Article Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to produce fermented foods. They are thus good candidates to develop novel oral vectors and constitute attractive alternatives to vaccinal strategies based on attenuated pathogens which could induce healthy risks. Here, we summarized the most recent researches performed on the use of LAB as live vaccine delivery vectors. Elsevier Masson SAS. 2009-12 2009-12-11 /pmc/articles/PMC7270964/ /pubmed/32518601 http://dx.doi.org/10.1016/S1773-035X(09)70312-0 Text en Copyright © 2009 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bermúdez-Humarán, Luis G.
Langella, Philippe
Utilisation des bactéries lactiques comme vecteurs vaccinaux
title Utilisation des bactéries lactiques comme vecteurs vaccinaux
title_full Utilisation des bactéries lactiques comme vecteurs vaccinaux
title_fullStr Utilisation des bactéries lactiques comme vecteurs vaccinaux
title_full_unstemmed Utilisation des bactéries lactiques comme vecteurs vaccinaux
title_short Utilisation des bactéries lactiques comme vecteurs vaccinaux
title_sort utilisation des bactéries lactiques comme vecteurs vaccinaux
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270964/
https://www.ncbi.nlm.nih.gov/pubmed/32518601
http://dx.doi.org/10.1016/S1773-035X(09)70312-0
work_keys_str_mv AT bermudezhumaranluisg utilisationdesbacterieslactiquescommevecteursvaccinaux
AT langellaphilippe utilisationdesbacterieslactiquescommevecteursvaccinaux